DERMALOGICA SUPER SENSITIVE FACE SPF 30
Natural health product licensed in Canada
- Licence holder
- Dermalogica (Canada) Inc.
- NPN or DIN-HM
- 80005547
- Status
- Inactive licence
- Licence date
- 21 April 2008
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Dioxyde de titane | 6.7 % |
Non-medicinal ingredients
Lauryl Peg-9 Polydimethylsiloxyethyl Dimethicone, silice, Cyclopentasiloxane, EDTA de tétrasodium, Tocophérol, hydroxyde d'aluminium, Glycyrrhizate de dipotassium, Ether dioctylique, PCA de sodium, citrate de sodium, Polygyceryl-3 Polydiméthylsiloxéthyl diméthicone, Polymère croisé de diméthicone/vinyl diméthicone, Acide stéarique, Sodium DNA, Hyaluronate de sodium, Diméthicone, Butylène glycol, Capric triglycéride, Lavandula hybrida, Chlorure de sodium, Carbomère, Ascorbyl tetraisopalmitate, Parahydroxybenzoate de méthyle, Phénoxyéthanol, Extrait de feuilles de Camellia Sinensis, PEG-10 Dimethicone Crosspolymer, acétate de tocophéryle, Triethoxysilylethyl polydimethylsiloxyethyl hexyl dimethicone, Eau, (p)-hydroxybenzoate de propyle, Linalool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
A sunscreen that contains Titanium Dioxide and Zinc Oxide invisibly defend against UVA and UVB rays. SPF 30.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80005547
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.